In this episode of the Thoughtful Entrepreneur, your host Josh Elledge speaks to the Chief Executive Officer and Founder of Xevant, Brandon Newman.\n\nBrandon Newman shared the challenges he faced when trying to afford his medications while providing for his family. He pointed out that around 10-15% of Americans struggle with the high costs of diabetes medications. He emphasized the importance of automation and real-time analysis in identifying opportunities to reduce costs and prevent the industry from breaking.\n\nBrandon shed light on the complexities of the healthcare industry, the escalating costs of medications, and the urgent need for affordable healthcare. He explained that Xevant's primary focus is to optimize pharmacy benefits for large healthcare companies. While this may not sound particularly thrilling, it's a critical aspect of healthcare dealing with trends, expenses, and drug access.\n\nXevant's mission is to help consumers reduce costs by providing access to lower-cost drugs, appropriate medications, and hidden benefits like rebates. They collaborate with employers, pharmacy benefit managers, health plans, and consultants to navigate the labyrinth of pharmacy benefits and optimize costs for the end payer.\n\nBrandon highlighted that the healthcare industry is shifting towards the pharmacy as the focal point, with high-cost specialty drugs and personalized drug development becoming more prevalent. Xevant is at the forefront of this shift, combining innovation and automation to provide real-time analysis and help patients find the most cost-effective and suitable medications.\n\nThe importance of access to affordable healthcare cannot be overstated, as it directly impacts people's health and quality of life. Brandon's experience with a health diagnosis fueled his motivation to create Savant and improve access to medication and healthcare.\n\n \nKey Points from the Episode:\n